NIH AIDS Reagent Program 产品代理

Antigen Preparations

Antimicrobial Compounds...

Bacteria

Bacteriophages

Cell Lines - Infected

Cell Lines - Uninfected

Clones

Libraries

Monoclonal Antibodies

Parasitic Protozoa

Peptides and Peptide Ar...

Plasmid or Vectors

Polyclonal Antiserum

Primers and Probes

Proteins

Viral Load Standards

Viruses 

The National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS (DAIDS) supports extramural basic and applied research to control and prevent diseases caused by HIV and other infectious agents. Through research grants and contracts, investigators develop and evaluate therapeutics, vaccines, and diagnostics to accomplish the mission of NIAID. An important rate-limiting step in basic and preclinical research is the identification and availability of high quality, authenticated research materials. To address this need, NIAID supports the Reagent Program for HIV and Other Infectious Diseases (NIH HIV Reagent Program or NIH HRP), previously known as the NIH AIDS Reagent Program, now the NIH HIV Reagent Program that serves as a central resource for a wide range of infectious agents and pathogens, biological materials, and chemicals for distribution to the scientific community. Since established in 1988, the program has evolved from a small bank of research materials, to offering over 3,000 critical products to the HIV/AIDS research community. The NIH HIV Reagent Program provides these materials to over 3,200 qualified investigators located in 65 countries.  

In addition to supplying the HIV/AIDS community with research materials, the NIH HIV Reagent Program encourages and supports the deposit of materials from researchers and institutions. Depositing materials with the NIH HIV Reagent Program has many advantages to the researcher and the research community including secure storage, community access and distribution; all while protecting the intellectual property rights of the depositor. The NIH HIV Reagent Program will be maintained as a resource for researchers as long as there is need.  Your deposit into the NIH HIV Reagent Program is a long term investment to aid future research.

The NIH HIV Reagent Program has been managed under contract by American Type Culture Collection (ATCC) since 2020.  ATCC shall maintain the NIH HIV Reagent Program through identification, acquisition, production, receipt, storage, maintenance, distribution and disposal of biological and chemical research organisms and materials for HIV and other infectious diseases for use in basic and translational research. ATCC shall also provide support for quality control and characterization of reagents, technology transfer, and execution of Material Transfer Agreements prior to release of reagents to the community.